Glenmark Generics receives ANDA approval for Levonorgestrel and Ethinyl Estradiol tablets

Glenmark Generics Inc USA has been granted final approval by the USFDA for the oral contraceptive Levonorgestrel/Ethinyl Estradiol Tablets USP, 0.09 mg/0.02 mg, the therapeutic equivalent to Lybrel of Wyeth Pharmaceuticals, Inc.

April 10, 2015 / 09:44 IST

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated April 10, 2015, titled "Glenmark Generics receives ANDA approval for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.09 mg/0.02 mg"Source : BSE

Read all announcements in Glenmark

first published: Apr 10, 2015 09:44 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Glenmark Generics receives ANDA approval for Levonorgestrel and Ethinyl Estradiol tablets

Glenmark Generics Inc USA has been granted final approval by the USFDA for the oral contraceptive Levonorgestrel/Ethinyl Estradiol Tablets USP, 0.09 mg/0.02 mg, the therapeutic equivalent to Lybrel of Wyeth Pharmaceuticals, Inc.

GP08